ZBH

Zimmer Biomet Holdings, Inc.

Healthcare

99.50 +0.10 +0.10% Pre-Market

2026-09-02 • USD

Key Metrics

Market Cap 18.98B

EV 26.05B

Shares Out 190.74M

Revenue (ttm) 8.51B

Net Income 806.70M

Beta —

P/E —

Forward P/E —

EPS (ttm) $4.12

P/S 2.25

P/B 1.51

P/FCF 12.56

P/C 10.97

EV/Sales 3.06

EV/EBITDA 11.26

ROA 3.49%

ROE 6.36%

ROIC 5.18%

Gross Margin —

Oper. Margin 14.16%

Profit Margin 9.48%

Debt/Eq 0.59

LT Debt/Cap 33.21%

Quick Ratio 0.72

Current Ratio 1.69

Book/sh 65.68

Cash/sh 2.13

Div Yield 0.96%

Div TTM $0.96

Payout Ratio 23.3%

SMA20 0.16%

SMA50 5.16%

SMA200 9.01%

Volume 1,392,108

Avg Volume 2.37M

Rel Volume 0.59

Perf Week -0.08%

Perf Month 2.50%

Perf Quarter 16.97%

Perf Half Y 1.46%

Perf YTD 10.54%

Perf Year -5.37%

Perf 3Y -16.79%

Perf 5Y -30.18%

Factor Lens

Seasonal Performance

Dividends

Per-share amounts adjusted for stock splits.

Last Dividend $0.2400

TTM Yield 0.96%

TTM Amount $0.96

Payout Ratio 23.3%

3-Yr Growth (CAGR) 0.00%

5-Yr Growth (CAGR) 0.00%

Last 12 Payouts

Period	Ex-Date	Amount / Share
Q2 2026	~2026-06-30	$0.2400
Q1 2026	~2026-03-31	$0.2400
Q4 2025	~2025-12-30	$0.2400
Q3 2025	~2025-09-30	$0.2400
Q2 2025	~2025-06-30	$0.2400
Q1 2025	~2025-03-31	$0.2400
Q4 2024	~2024-12-30	$0.2400
Q3 2024	~2024-09-30	$0.2400
Q2 2024	~2024-06-30	$0.2400
Q1 2024	~2024-03-31	$0.2400
Q4 2023	~2023-12-30	$0.2400
Q3 2023	~2023-09-30	$0.2400

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Zimmer Biomet Holdings, Inc. is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. The company designs,…

Name: Zimmer Biomet Holdings, Inc.
Industry: Medical Instruments & Supplies
CEO: Ivan Tornos · Chairman, President and Chief Executive Officer
Employees: —
IPO Date: 2017-07-11
Phone: (574) 373-3333
Address: 345 East Main Street, Warsaw, IN 46580
Website: www.zimmerbiomet.com

Key Executives

Name	Title	FY Pay
Kevin Thornal	Executive Officer	—
Jehanzeb Noor	Executive Officer	—
Wilfred Van Zuilen	Executive Officer	—
Suketu Upadhyay	Chief Financial Officer	—
Ivan Tornos	Chairman, President and Chief Executive Officer	—

Latest News

2026-04-21
Zimmer Biomet (ZBH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release zacks.com
2026-04-20
Here's How Zimmer Biomet Is Placed Ahead of Q1 Earnings zacks.com
2026-04-17
Financial Comparison: Generation Alpha (OTCMKTS:GNAL) & Zimmer Biomet (NYSE:ZBH) defenseworld.net
2026-04-10
Douglas Lane & Associates LLC Raises Holdings in Zimmer Biomet Holdings, Inc. $ZBH defenseworld.net
2026-04-09
Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2026 Financial Results prnewswire.com
2026-04-07
Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer prnewswire.com
2026-04-07
Aberdeen Group plc Trims Stock Position in Zimmer Biomet Holdings, Inc. $ZBH defenseworld.net
2026-04-05
Head-To-Head Analysis: SNDL (NASDAQ:SNDL) and Zimmer Biomet (NYSE:ZBH) defenseworld.net

ZBH